STONY BROOK, NY--(Marketwire - December 21, 2012) - Applied DNA Sciences, Inc. (OTCBB: APDN), a DNA security solutions company, today announced that its Annual Meeting of Stockholders will be held on Friday March 1, 2013 at 10:00 AM EST at the Center of Excellence in Wireless and Information Technology (CEWIT) Stony Brook, New York. Directions to CEWIT can be found at www.adnas.com. APDN also announced that its Board of Directors has set the close of business on Wednesday January 2, 2013 as the record date for determining who may vote at the meeting. All stockholders as of the record date are invited to attend the Annual Meeting where Dr. James Hayward, President and CEO will discuss the latest accomplishments of the company.
APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.
The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 20, 2012 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.